Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Cell Research|September 25, 2013
Hepatitis C: a mouse at the end of the tunnelMarco Binder, Ralf BartenschlagerViruses|January 8, 2020
Gene Expression Profiling of Different Huh7 Variants Reveals Novel Hepatitis C Virus Host FactorsChristopher Dächert, Evgeny Gladilin, Marco BinderFEMS Microbiology Reviews|December 7, 2011
Failure of innate and adaptive immune responses in controlling hepatitis C virus infectionRobert Thimme, Marco Binder, Ralf BartenschlagerCurrent Opinion in Virology|June 26, 2024
Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antiviralsFelix Fiehn, Claudia Beisel, Marco BinderHepatology (Baltimore, Md.)|August 3, 2007
Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategyMarco Binder, Georg Kochs, Ralf Bartenschlager, et al.Cells|October 23, 2021
Comparative Analysis of Six IRF Family Members in Alveolar Epithelial Cell-Intrinsic Antiviral ResponsesSandra Wüst, Paulina Schad, Sandy Burkart, et al.European Journal of Immunology|August 8, 2009
Bacterial RNA is recognized by different sets of immunoreceptorsFlorian Eberle, Mehtap Sirin, Marco Binder, et al.Archives of Virology|January 13, 2023
Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidoneGeorgios-Dimitrios Panagiotidis, Christin Müller, Marco Binder, et al.Journal of Hepatology|September 24, 2022
Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replicationNadine Gillich, Zhenfeng Zhang, Marco Binder, et al.Journal of Theoretical Biology|May 25, 2020
Mechanistic modeling explains the dsRNA length-dependent activation of the RIG-I mediated immune responseDarius Schweinoch, Pia Bachmann, Diana Clausznitzer, et al.Pageof 8